CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	IPO	Class A common stock	Common Stock Class A common stock	Common Stock Class A common stock IPO	Additional paid in capital	Additional paid in capital IPO	Accumulated deficit	Accumulated comprehensive income (loss)	Non-controlling Interest
Beginning balance, common stock (in shares) at Dec. 31, 2022				153,629,000
Beginning balance, common stock at Dec. 31, 2022	$ 384,760			$ 18		$ 535,875		$ (154,754)	$ (7)	$ 3,628
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock awards plans (in shares)				9,835,000
Issuance of common stock under employee stock option and stock award plans	5,904					5,904
Stock-based compensation expense related to employee and non-employee stock awards	45,043					45,043
Stock issued (in shares)				4,232,000	11,500,000
Stock issued	4,399	$ 86,462			$ 3	7,509	$ 86,459			(3,110)
Net loss	(145,951)							(145,433)		(518)
Ending balance, common stock (in shares) at Dec. 31, 2023			179,196,418	179,196,000
Ending balance, common stock at Dec. 31, 2023	380,617			$ 21		680,790		(300,187)	(7)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock option and stock awards plans (in shares)				8,918,000
Issuance of common stock under employee stock option and stock award plans	12,759			$ 1		12,758
Stock issued	39,236					39,236
Net loss	(84,599)							(84,599)
Ending balance, common stock (in shares) at Dec. 31, 2024			188,114,202	188,114,000
Ending balance, common stock at Dec. 31, 2024	$ 348,013			$ 22		$ 732,784		$ (384,786)	$ (7)	$ 0